Low-protein diets trigger distinct molecular responses in the liver during aging, mediated both through and independent of FGF21 signaling. This dual-pathway mechanism reveals how nutrient restriction at the transcriptomic level may influence metabolic adaptation and longevity outcomes across the lifespan.
Key Points
- FGF21 mediates specific transcriptomic changes in response to low-protein feeding.
- Non-FGF21 pathways drive additional liver adaptations to protein restriction.
- Aging modulates how the liver interprets and responds to protein scarcity signals.
Longevity Analysis
The liver's ability to decode nutrient availability and mount coordinated molecular responses directly affects how efficiently the body processes energy, regenerates tissue, and maintains hormonal balance across the aging process. When protein intake drops, the liver doesn't rely on a single signaling mechanism—it activates multiple parallel pathways to optimize metabolic function. Understanding which responses depend on FGF21 and which operate independently allows practitioners to distinguish between hormonal interventions that might replicate protein-restriction benefits and those that may not. This distinction matters because aging itself alters how robustly these pathways function, meaning dietary or pharmaceutical strategies that work in younger individuals may require different implementation in older populations.
Original published by Nature - npj Aging, by Jose A. Godoy-Lugo.